Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
By reducing NNMT catalytic activity, the compound allows researchers to evaluate how limiting nicotinamide methylation influences: In vitro and in vivo experimental models (non-clinical, non-human) have demonstrated that NNMT suppression leads to measurable changes in cellular energy markers and adipocyte behavior
The results are more modest but also more sustainable and safer
Advanced reconstitution considerations Beyond the basics, several nuances can further optimize your reconstitution results
Bibcode:1998JAFC...46..206W
How AOD-9604 Works (in Brief) AOD-9604 was engineered from the C-terminal segment of human growth hormone (amino acids 177191) the portion thought to influence fat metabolism. In preclinical models, this fragment supported fat oxidation and lipid mobilization without the broader hormonal effects of full-length hGH. Because it does not activate the traditional hGH receptor, its fat-metabolism effects are considered indirect and receptor-independent. Discovery & Research Milestones Originally developed in the 1990s as a potential anti-obesity drug
Before I lifted 500 pounds, do you know what I did
US$ 28.93
US$ 29.42
US$ 29.00
US$ 28.71
US$ 25.77
